iCAD to Present at Canaccord Adams 27th Annual Global Growth Conference
NASHUA, N.H., July 25 /-- iCAD, Inc. (NASDAQ:iCAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that Ken Ferry, President and Chief Executive Officer of iCAD, will be presenting at the Canaccord Adams 27th Annual Global Growth Conference on Tuesday, August 7, 2007 at 11 a.m. (Eastern Daylight Time) at the Intercontinental Hotel in Boston.
The presentation will be webcast live and archived for replay on the "Investors" section of the company's website at www.icadmed.com.
An audio webcast of the presentation will be available after the conference at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ICAD&item_id=1609758.
About iCAD, Inc.
iCAD, Inc. (NASDAQ:iCAD) is an industry-leading provider of Computer- Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over one thousand women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit www.icadmed.com.
FCMN Contact: kambrogio@schwartz-pr.com
Source: iCAD, Inc.
CONTACT: Darlene Deptula-Hicks of iCAD, EVP and CFO, +1-603-882-5200, ext. 7944, ddeptula@icadmed.com; or Investors, Kevin McGrath of Cameron Associates, +1-212-245-4577, kevin@cameronassoc.com, for iCAD, Inc.; or Media, Wendy Ryan of Schwartz Communications, +1-781-684-0770, icad@schwartz-pr.com, for iCAD, Inc.
Web site: www.icadmed.com/
